Clinical Trials Directory

Trials / Completed

CompletedNCT05569135

Debridement and Laser Ablation Versus Debridement Alone in Pilonidal Disease

Debridement and Laser Ablation Versus Debridement Alone in Pilonidal Disease: Retrospective Analysis of Mid-term Outcome

Status
Completed
Phase
Study type
Observational
Enrollment
121 (actual)
Sponsor
Istanbul Medipol University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

This study aims to investigate the effect of laser ablation (LA) in minimally invasive management of pilonidal disease (PD). Data of the patients with PD who were eligible for simple debridement have been prospectively collected since March 2018, when laser ablation treatment came into use in our institution. Laser ablation treatment was offered to all eligible patients. All the patients underwent debridement (removal of hair and/or necrotic tissues through pits using a clamp/curette/brush) of PD; LA was added to the procedure in patients who were willing to have LA. The surgical outcome of two procedures was compared. The primary outcome measure was recurrence at 36 months.

Conditions

Interventions

TypeNameDescription
DEVICELaser ablationA diode-laser that has been reported to be safe and effective in several treatments including pilonidal disease, anal fistula, hemorrhoids, and vascular ablation was used to obtain shrinkage of pilonidal cyst

Timeline

Start date
2018-03-01
Primary completion
2019-10-03
Completion
2022-10-03
First posted
2022-10-06
Last updated
2022-10-06

Locations

1 site across 1 country: Turkey (Türkiye)

Regulatory

Source: ClinicalTrials.gov record NCT05569135. Inclusion in this directory is not an endorsement.